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Abstract
Background: Self-management support programmes are effective in a range of chronic conditions however there
is limited evidence for their use in the treatment of chronic headaches. The aim of this study was to test the
feasibility of four key aspects of a planned, future evaluative trial of a new education and self-management
intervention for people with chronic headache: 1) recruiting people with chronic headache from primary care; 2) a
telephone interview for the classification of chronic headaches; 3) the education and self-management intervention
itself; and 4) the most appropriate patient reported outcomes (PROMS).
Methods: Participants were identified and recruited from general practices in the West Midlands of the UK. We
developed a nurse-led chronic headache classification interview and assessed agreement with an interview with
headache specialists. We developed and tested a group based education and self-management intervention to
assess training and delivery receipt using observation, facilitator, and participant feedback. We explored the
acceptability and relevance of PROMs using postal questionnaires, interviews and a smartphone app.
Results: Fourteen practices took part in the study and participant recruitment equated to 1.0/1000 registered
patients. Challenges to recruitment were identified. We did 107 paired headache classification interviews. The level
of agreement between nurse and doctor interviews was very good. We piloted the intervention in four groups with
18 participants. Qualitative feedback from participants and facilitators helped refine the intervention including
shortening the overall intervention and increasing the facilitator training time. Participants completed 131 baseline
questionnaires, measurement data quality, reliability and validity for headache-specific and generic measures was
acceptable.
Conclusion: This study indicated that recruiting people with chronic headache from primary care is feasible but
challenging, our headache classification interview is fit for purpose, our study intervention is viable, and that our
choice of outcome measures is acceptable to participants in a future randomised controlled trial (RCT).
Trial registration: ISRCTN, ISRCTN79708100. Registered 16th December 2015, http://www.isrctn.com/
ISRCTN79708100
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Background
Self-management support programmes have an estab-
lished place in the management of a range of chronic dis-
eases [1], however evidence for self-management
programmes for use in chronic headaches disorders is cur-
rently limited [2]. The National Institute for Health Re-
search (NIHR) funded a programme of work (RP-PG-
1212-20,018) to develop, and test, a non-pharmacological
approach for chronic headache using education and
self-management. NIHR programme grants fund research
for conditions that cause substantial disease burden and
usually consist of ‘an interrelated group of high quality
projects focused on a coherent theme, requiring multidis-
ciplinary approaches, including clinical, health economics,
statistics, qualitative and behavioural sciences, to ensure
that research objectives can be met’. [3] Here we report
the findings from a feasibility study we completed as part
of our programme of work in preparation for a rando-
mised controlled trial (RCT) evaluating the effectiveness
of the intervention.
We wanted to test the feasibility of four key aspects
prior the planned trial. Firstly, we wanted to test the feasi-
bility of recruiting people with chronic headache from pri-
mary care and estimate the population base needed to
recruit enough participants for the trial. Nearly a fifth of
trials in 2011 were terminated for not meeting sufficient
recruitment targets, and therefore unable to answer their
research questions meaningfully [4].
Secondly, we needed to be able to classify common
chronic headaches in participants identified from pri-
mary care. Specifically we wanted to test the feasibility
of using a telephone classification interview that can be
used by a non-headache specialist to classify the com-
mon chronic headache disorders: chronic migraine,
chronic tension type headache (TTH) and medication
overuse headache (MOH). Many people with chronic
headache disorders do not have an accurate diagnosis
and receive inappropriate treatment of their headaches
[5]. We wanted the classification interview to allow
classification of headache type for both reporting and
analysis purposes and to be used as part of the study
intervention to allow targeted, individualised, treatment
and advice. A systematic review failed to identify a sim-
ple classification tool fit for our purpose, we therefore
needed to develop and validate a tool which can be
used by a non-headache specialist to classify common
chronic headache disorders [6].
Thirdly, we wanted to test the feasibility of developing
and delivering the education and self-management sup-
port intervention for the management of common chronic
headache disorders and examine the acceptability of the
intervention to participants. Evaluations of complex inter-
ventions can be undermined by problems of acceptability,
compliance and delivery of interventions [7].
Finally, we wanted to test the quality, acceptability and
appropriateness of patient reported outcome measures
(PROMs) for the trial. The selection of appropriate out-
comes is crucial to the design of a trial and outcomes need
to be relevant to people with chronic headaches [8]. A sys-
tematic review of the quality and acceptability of patient-
reported outcome measure highlighted the paucity of
good quality PROM evaluations in this population and the
limited focus on measurement relevance and acceptability
to end-users, that is, people with headache [9]. We there-
fore wanted to understand which outcomes are important
and relevant to people with chronic headache, a popula-
tion who are often young adults with work and family
commitments. Additionally, electronic diaries have shown
to be acceptable to participants and may have the advan-
tage of reducing recall effects [10, 11]; we wanted to test
the feasibility of using a smartphone app to collect weekly
data on headache frequency, duration and severity.
Methods
This feasibility study was designed to determine what
can be done, what should be done and how it can be
done well for a future RCT [12]. It was a mixed method
study to test and evaluate the feasibility of a newly de-
veloped education and self-management intervention
for chronic headaches, future trial recruitment methods
and the most appropriate outcome measures. It in-
cluded, in addition, an embedded reliability study for
the classification of headaches disorders, reported in
more detail elsewhere [13]. The components of the
feasibility study are shown in Fig. 1. We did not con-
duct a full pilot trial but chose to test the feasibility of
four crucial components of the main randomised con-
trolled trial due to the complexity and importance of
each of these components. The study ran from January
2016 to April 2017.
Patient and public involvement
Patient and public involvement (PPI) was built into the key
stages of the feasibility study to ensure that the research fo-
cused on issues that were important and relevant to pa-
tients and the public [14]. At the start of the study we
established a lay advisory group of people with chronic
headache to work with collaboratively. We identified mem-
bers of the group from Universities/User Teaching and Re-
search Action Partnership (UNTRAP) at the University of
Warwick and sent out an advert to our three partner head-
ache groups: Migraine Trust, Migraine Action and National
Migraine Centre (In 2018 Migraine Action merged with
Migraine Trust). The CHESS Lay Advisory Group specific-
ally supported our application for ethical approval for the
study, development of the headache classification interview,
development of the study intervention and the choice of
patient reported outcome measures.
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Feasibility of recruiting people with chronic headache
from primary care
The aim of this part of the study was to test the feasibility
of our recruitment procedures and recruit a sample of
participants to test the telephone headache classification
interview, to pilot the education and self-management
intervention, and to test the feasibility and the outcomes
measures.
Setting
We aimed to recruit patients with chronic headache
registered with general (family) practices in the West
Midlands region of the UK. We ran the study in three
clinical commissioning groups (CCGs) in the West
Midlands which cover urban, small town and semi-
rural areas with varying levels of deprivation and ethnic
diversity. We initially ran the study in five Clinical Re-
search Network (CRN) West Midlands South ‘host
practices’ with extensive research experience. Subse-
quently we purposively selected additional practices to
maximise diversity and to fill groups for the pilot inter-
vention. We sought feedback via email using a short
structured questionnaire from a small sample of Gen-
eral Practitioners (GPs) from the participating practices
to explore their experience of taking part in the study.
Participants
The eligibility criteria for the feasibility study were:
Inclusion Criteria:
1. Aged ≥18 years with chronic headache; defined as
headache for 15 or more days per month for at
least 3 months.
2. Able and willing to comply with the study
procedures and provide written consent.
3. Fluent in written and spoken English.
Exclusion Criteria:
1) Has an underlying serious psychiatric or
psychological disorder that precludes participation
in the group intervention.
2) Known secondary cause of headache other than
medication overuse headache; e.g.: primary or
secondary brain tumour.
3) No access to a telephone.
Fig. 1 Components of the Feasibility Study
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4) Currently participating in another clinical trial (with
an unregistered medicinal product), or less than 90
days have passed since completing participation in
such a trial.
The recruitment process to identify people for the
study involved a standardised electronic search for gen-
eral practice databases using Read-codes [15]. Initial
scoping work indicated this standard clinical termin-
ology system for coding chronic headache was rarely
used, we therefore devised a search strategy to identify
patients aged ≥18 years who had consulted with head-
ache (migraine, TTH and medication overuse headache)
or had been prescribed migraine specific drugs (i.e.
triptans, pizotifen) in the preceding 12 months. GPs
then screened the list for patients it would be inappro-
priate to approach e.g. poorly controlled serious mental
illness, terminal illness, or known secondary causes of
headache other than medication overuse headache.
Potentially eligible patients were invited to participate in
the study by a letter from their GP which also included a
patient information leaflet informing them about the
study. We also designed a study poster for display in pa-
tient waiting areas. People interested in the study were in-
vited to contact the study team and asked the following
questions to confirm eligibility:
1. On average how many days in the month do you
get headaches?
2. How long have you been having your headaches
this frequently for?
3. Has this been for at least the last 3 months?
4. Are you currently taking part in a drug trial?
Patients who met the eligibility criteria were informed
that they would be asked to complete two telephone
headache classification calls (one by a nurse the second
by a headache specialist doctor) and that they may be
invited to attend the education and self-management
programme and/or take part in the interview study. Po-
tential participants also had the opportunity to have
any questions answered regarding the study.
Baseline packs were sent to people who were eligible
and interested in the study, they included a consent form,
a baseline questionnaire and a freepost return envelope. If
necessary, a reminder pack was sent after 2 weeks. All par-
ticipants were asked to provide written consent to
complete postal questionnaires, a Smartphone App and
the two telephone classification interviews. Study entry
was marked by receipt of the signed consent form.
Sample size
For the suite of work in the feasibility study we initially
sought to recruit 170 people with chronic headaches
from primary care. The driver for this sample size was
to have sufficient data to allow us to assess the
inter-rater reliability of the telephone classification inter-
view when done by two raters; namely a nurse, and a
doctor experienced in headache management. We as-
sumed level of agreement to be 0.8, a substantial agree-
ment [16]. The initial sample size was based on
measuring the level of agreement for the classification
of migraine (yes/no), TTH (yes/no) and MOH (yes/no).
Following our systematic review of diagnostic tools and
our classification consensus meeting, the outcomes
from the classification changed to measuring the level
of agreement in the classification of definite chronic
migraine, probable chronic migraine and chronic TTH
as well as presence or absence of MOH as a nominal
scale. As the analyses changed from three pairwise
comparisons to two pairwise comparisons, the multipli-
city adjustment also changed hence giving a revised
sample size target of 153 paired interviews which was
approved by the programme steering committee and
the funder [17].
An initial pilot search suggested that around 30/1000
people registered with a GP consult for headaches
(acute, episodic or chronic) annually. Assuming that a
third of these consulters had chronic headaches and a
quarter of these joined the feasibility study recruitment
rate would be 2.5/1000 or 8.3% of those identified as
consulting with headaches. Based on an average prac-
tice population of 7000 we estimated we needed 6–10
practices with a combined list size of 64,000 people to
recruit our sample.
Feasibility of a telephone classification interview to
classify common headache disorders
We developed a telephone headache classification
interview for use by a non-headache specialist to clas-
sify chronic headache types for reporting and analysis
purposes and that could also be used as part of the
study intervention to allow targeted treatment and ad-
vice. In brief, we did a systematic literature review to
identify any existing tools used to classify or diagnose
different headache types which was presented to dele-
gates at a headache classification consensus confer-
ence attended by headache specialists and people with
chronic headache [6]. At the consensus conference
delegates agreed what were the important questions to
include in the classification interview. The classifica-
tion interview was not intended to have a rigid inter-
view structure or set questions, instead the person
conducting the interview was encouraged to use a
logic model to inform their clinical reasoning and
decision-making.
We aimed to test the feasibility of training nurses to use
the classification interview to classify chronic headache
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disorders and test the reliability of the tool. To validate
the classification interview we trained six nurses, all
non-headache experts, to conduct the interviews. The
training included a one-day workshop delivered by a neur-
ologist specialised in headache plus time with a member
of the study team to practice classification interviews
using mock scenarios and a training manual.
Participants from the feasibility study were interviewed
first by the nurse and later by a doctor from the National
Migraine Centre. The doctor classification was the as-
sumed ‘gold standard’. Participants were classified into:
definite chronic migraine, probable chronic migraine or
chronic TTH (with or without medication overuse) or
‘other’ headache type (other chronic primary headache
or suspected secondary headache). We measured level of
agreement between the classifications by nurses and
doctors by using simple kappa statistics and prevalence-
adjusted bias-adjusted kappa (PABAK).
The development and evaluation of the telephone
headache classification interview is described in detail
elsewhere [13].
Feasibility and acceptability of the education and self-
management support intervention for chronic headache
We developed the education and self-management
intervention using the Medical Research Council
(MRC) framework for complex interventions [7]. De-
velopment was informed by three systematic reviews
1.prognostic factors in chronic headache [18], 2. educa-
tion and self-management interventions for chronic
headache [19] and 3. the lived experiences of chronic
headache. We drew from the experience of a previously
tested self-management intervention for chronic pain
[20] and we did qualitative interviews with people with
chronic headache to inform the intervention design.
The qualitative interviews were with members of the char-
ity Migraine Action to gain their views on what was im-
portant to include in the education and self-management
intervention. We held a collaborative intervention design
meeting, attended by headache specialist clinicians, head-
ache charity representatives, lay people with chronic head-
ache, psychologists, and researchers.
The education and self-management intervention was
intended to be delivered in a group format (8–10 per
group) facilitated by a nurse and a lay person (with
chronic headache). Topics included in the intervention
were: understanding headache mechanisms, medication
management, mood and headache, recognising unhelpful
thought patterns and behaviours, stress management,
sleep management, communication and mindfulness. The
two and a half day programme used a range of methods
including: group discussions, sharing narratives and expe-
riences, problem solving, watching an educational DVD,
role play and taster sessions. This was followed by a one
to one consultation with a nurse to classify their headache
type and discuss medication, lifestyle factors and goal set-
ting, and up to 8 weeks of telephone support.
The development of the education and self-
management interventions is described in detail else-
where [21].
We aimed to test the feasibility of the new interven-
tion by running four groups each with up to 10 partici-
pants in community settings. We approached people
who lived within easy travelling distance of proposed
groups; participants provided written consent to attend
the group intervention. We wanted to recruit and train
two lay people and three nurses to deliver the interven-
tion. The acceptability of the intervention was explored
by conducting qualitative interviews with the partici-
pants who attended the groups and the facilitators that
delivered the groups. Thematic analysis was used to
identify common themes across the different compo-
nents of the intervention.
Feasibility of the patient reported outcome measures
We proposed that our primary outcome measure for the
RCT would be a headache-specific outcome measure col-
lected by postal questionnaire. We initially did a systematic
review of the quality and acceptability of patient reported
outcome measures for episodic and chronic headache dis-
orders [9], and a qualitative review of the lived experience
of chronic headache [22] to understand what outcomes
are important to people with chronic headache. This
process supported the short-listing of both headache-spe-
cific (Migraine-Specific Questionnaire v2.1(MSQv2.1) [23]
and the Headache Impact Test 6-item (HIT-6) [24] and
generic measures (EuroQoL EQ-5D-5 L) [25] and
Short-Form 12-item Health Status questionnaire (SF-12)
[26] to include in the feasibility study. However, the
migraine-specificity of the MSQv2.1 [23] made it unsuit-
able for use with our chronic headache population. There-
fore, with permission from the developers, the target
attribute of ‘migraine’ was changed to ‘headache’ and the
questionnaire renamed as the ‘Chronic Headache Quality
of Life Questionnaire’ (CHQLQv1.0). We evaluated both
the acceptability and psychometric performance (data
quality, reliability, validity) of the modified measure against
the HIT-6, EQ-5D-5 L and SF-12 [24–26], providing the
first evidence for the performance of the CHQLQ and
HIT-6 [24] in a UK population and supporting selection
for the RCT. Structured cognitive interviews were also
conducted to explore the acceptability and relevance of
the measures. Informed by good practice guidance, the
interviews explored how responder’s made judgements
when completing the PROMs, including aspects such as
question comprehension, recall and ease of completion
[27, 28]. The cognitive interviews and their analysis was
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carried out by an experienced qualitative team with ex-
pertise in this area.
Data collection
All participants were asked to complete postal question-
naires with the selected measures CHQLQ, HIT-6, SF-12
and EQ-5D-5 L at baseline (the point of consent) and at 2
weeks and 12weeks after the baseline questionnaire was
returned. The study team posted the questionnaire with a
covering letter and a freepost return envelope. After 1
week if the questionnaire had not been received a re-
minder was sent and, 1 week following the reminder a
telephone call would be made if the questionnaire was not
received.
A smartphone application (app) compatible with
IPhones, IPads and Android devices was designed by
Clinvivo Ltd. for use in the study. The app asked partic-
ipants to complete three simple questions regarding the
frequency, severity and duration of the headaches they
experienced. The questions were developed with the in-
volvement of the CHESS Lay Advisory Group. The app
requested the data to be completed weekly for up to 12
weeks and provided notification reminders for those
who accepted this option. A small number of partici-
pants were approached to test the app; these were all
participants who had recently agreed to take part in the
study at the time the app was ready for testing.
Results
Feasibility of recruiting people with chronic headache
from primary care
Practice recruitment
We recruited 14 general practices with a combined practice
population of 128,634 (range 3300 to 16,886), see Fig. 2.
Feedback from the short structured email questionnaire to
GPs indicated that practices were mainly interested in the
study because they felt a self-management programme
Fig. 2 Practice and participant recruitment consort chart
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could potentially provide a useful alternative option for the
management of patients with frequent headaches.
Participant recruitment
Searches of general practice data bases identified 1827
potential participants (14.2/1000 of registered patients).
GPs excluded 184 (10%) of these as inappropriate to ap-
proach. The remaining 1634 (1.3% of total list size) were
invited to take part in the study. We received 586 (36%)
responses, of these 393 (24%) were interested in being
contacted by the study team; 193 were not interested in
the study. We succeeded in contacting 361/393 (92%)
often after numerous attempts to get hold of people; of
these potential participants 175 (48% of those contacted,
11% of those 1634 invited) were eligible. We received
valid consent forms from 75% (131/175) of eligible par-
ticipants (8% of those 1634 invited). Forty people failed
to respond and four formally withdrew at this stage. We
recruited 1.0/1000 of practice list size.
Participants mean age was 49 years (range 21–77,
standard deviation, SD, 13.3). There were 108 (82%) fe-
male participants, 125 (95%) of white ethnicity and 86
(66%) in full or part-time employment. About one third
(n = 47, 36%) left full time education between age 17 and
19, and another third (n = 44, 34%) left full time educa-
tion after 20 years old (Table 1).
Feasibility of the headache classification interview
We trained six research nurses to conduct the tele-
phone classification interviews. Feedback from the
training indicated that the nurses felt that the training
workshop, opportunity to practice interviews and the
training manual prepared them adequately to carry out
the classification calls and that they gained confidence
the more interviews they completed. Nurses and doc-
tors from the NMC completed 111 and 108 headache
classifications interviews respectively. There were 107
paired interviews. Median days between interviews was
32 (interquartile range, IQR, 21 to 48 days). Proportion
of concordance of agreement between nurses’ and doc-
tors’ interviews was 0.91, with moderate or very good
agreement on PABAK agreement in main and sensitiv-
ity analyses respectively. Full details of these analyses
are reported elsewhere [13].
Feasibility of the education and self-management support
intervention
We approached 85 participants to pilot the education and
self-management programme; we were unable to contact
12 (14%) participants and 46 (54%) participants were un-
able to attend, reasons included work commitments, dates
being unsuitable, home life (including childcare) and holi-
days (Fig. 3), 27 (32%) expressed interest in attending the
intervention and of these 18 (21%) provided written con-
sent to attend a group.
We piloted the CHESS intervention in four groups
and with a total of 18 participants. The attendance at
groups ranged from 3 to 6 participants and 17 partici-
pants attended the one-to-one consultation with the
nurse. Qualitative interviews were completed with 12
participants using topic guides to explore participants’
experience of taking part in the intervention. On the
whole the groups were considered acceptable and par-
ticipants found the educational and self-management
components useful and interesting and found the op-
portunity to meet with other people with chronic head-
ache particularly helpful. Based on participant feedback
we removed the half day follow-up session because par-
ticipants found the time commitment too great and we
included the sessions on communication and managing
setbacks at the end of day two of the programme.
Facilitators gave us feedback in a focus group or inter-
views with the use of topic guides, including their expe-
riences of delivering the intervention and the training
received. They reported that they did not find the two-
day training adequate time to cover the delivery of the
group intervention and the headache classification and
medication information for the one-to-one consulta-
tions. It was also difficult for the lay facilitators to com-
mit to delivering the intervention due to existing work
and family commitments and unpredictability of their
own headaches.
Feasibility of the patient reported outcome measures
Participants completed and returned 131 baseline ques-
tionnaires; 115 (88%) and 103 (79%) questionnaires were
returned at two and 12-week follow up respectively. Meas-
urement data quality, reliability and validity for the
headache-specific and generic measures was reached at
acceptable standards [29, 30], supporting application of
the measures with groups of patients with chronic head-
ache. Participants in the cognitive interviews (n = 14) indi-
cated items included in the CHQLQ were comprehensive
in scope and particularly welcomed those referring to the
emotional impact of headache, and found the measure
easy to complete. The lack of recall period for the first
three items of the HIT-6 was a concern. The generic mea-
sures were considered to be acceptable.
In total eight participants downloaded the Smartphone
App, participants completed the app for a duration of up
to 11 weeks. A telephone call was made to a selection of
participants to check they were happy using the app and
although participants didn’t report difficulties download-
ing or using the app only one participant completed all
11 weeks of data collection and only four participants
completed half or more of the weeks.
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Discussion
One of the key objectives for the study was to test the
feasibility of recruiting people with chronic headache from
primary care and estimate the population base needed to
recruit enough participants for the RCT. We successfully
recruited 14 general practices to the study and feedback
from GPs suggested that an invitation to participate in a
randomised controlled trial is likely to be well received by
general practices.
Recruitment to the study equated to around one per
1000 of the list size; this is comparable to recruitment
rates from general practice for other studies of chronic
pain [20, 31, 32]. It is, however, substantially less than our
pre-study assumptions. The number of people with
headaches across our pool of 14 practices was a little
under half of that anticipated and the conversion rate
of 7.1% from identification to consent was slightly less
than pre-study assumptions. The highest identification
rate was 18.3/1000 ranging down to 8.1/1000 (data not
shown) suggesting that whilst there is great variability
in coding of headache in practices our initial scoping
searches were erroneous. Our conversion rate estimate
was slightly optimistic and again there was a wide vari-
ability in conversion rate by practice (3.3 to 9.4%, data
not shown). Consequently a wide range in recruitment
rate (0.6/1000 to 1.6/1000, data not shown). This means
we under-recruited against our original target and will
need to recruit participants from over 100 practices for
the RCT.
Overall we gained much useful information and ex-
perience from the recruitment processes for this feasi-
bility study and we have made some important changes
to our approach for the main study including allowing
self-referral to the study from posters in pharmacies
local to participating general practices and word of
mouth media exposure. Contacting a largely young
working population was challenging often requiring nu-
merous attempts by telephone and email and a flexible
approach to contacting people outside usual working
hours. Only 75% of those eligible to take part returned
signed consent forms despite chasing.
We had also not fully anticipated the challenges of
making paired headache classification calls meaning we
had data on fewer people than originally planned. Never-
theless we did obtain sufficient data to evaluate the
agreement between nurse and doctor interviews. Non-
headache specialist nurses were able to use our logic
model to classify chronic headaches types and identify
medication overuse headache and the level of agreement
with interviews by doctors specialised in headache was
good, giving us confidence in the classification interview
in the RCT.
We successfully piloted the intervention in four
groups and gained valuable feedback from participants
and facilitators. The length of the group intervention
was reduced by half a day because participants, found it
hard to commit more time due to work and family
commitments. Nurse facilitators requested more train-
ing in order to feel confident in headache classification
and medication advice, and an additional day training
has been added in the RCT. The group intervention
was originally designed to be facilitated by a health pro-
fessional and lay person with chronic headache, a
model which has previously been successful for the de-
livery of group interventions for chronic pain [20]. Be-
cause of the unpredictability of their own headaches it
was not possible for the lay facilitators to commit to




Age (years) N 128
Mean (sd) 48.9 (13.3)
Median (IQR) 49 (38.5,58)
Missing 3
Gender Male 21 (16%)
Female 108 (82%)
Missing 2 (2%)
Ethnicity White 125 (95%)
Black or Black British 2 (2%)




Employment Employed (full or part-time including
self-employment)
86 (66%)
Unemployed and looking for work 0
At school or in full time education 2 (2%)
Unable to work due to long term
sickness
3 (2%)
Looking after your home/family 11 (8%)
Retired from paid work 22 (17%)
Other 3 (2%)
Missing 4 (3%)
Age left full time
education





Still in full time education 3 (2%)
Other 1 (1%)
Missing 1 (1%)
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the role, and in the RCT the intervention will be facili-
tated by a nurse and an allied health professional.
Alongside the RCT we will run a process evaluation to
help understand how and if the intervention works.
This will include collecting data on group attendance
and interviews with a sample of participants and facili-
tators to explore the experience of delivering and re-
ceiving the intervention to inform any future roll out of
the programme.
The completion and follow up of postal questionnaires
was good, and all measures were well completed by re-
sponders at all time-points. Acceptable levels of data qual-
ity, reliability and validity were found for all measures,
supporting their use with groups of people and justifying
selection for the RCT. Participants indicated that the modi-
fied measure the Chronic Headache Quality of Life Ques-
tionnaire was both comprehensive and comprehensible.
We were able to test our Smartphone App prior to the
RCT in a small sample of participants, completion rates
were poorer than anticipated and strategies to improve level
of completion will be implemented in the main trial.
The advice and support of PPI was integral to the
intervention development and other aspects of the feasi-
bility study and the lay advisory group will continue
their contribution into the main RCT.
The findings from the feasibility study have allowed
us to be confident we are selecting the right partici-
pants and have a viable intervention, and allowed us to
make an informed choice about outcome measures for
the RCT. The feasibility study also identified challenges
in recruitment of participants with chronic headache
from primary care and collecting patient reported out-
come measures that we have learnt from before starting
the main trail.
The CHESS RCT (ISRCTN 79708100) which com-
menced January 2017 will test the effectiveness and cost
effectiveness of the group education and self-management
intervention compared with a best usual care and a relax-
ation CD for people living with chronic headaches
(ISRCTN 79708100).
Conclusions
This study has demonstrated that recruiting people with
chronic headache from primary care requires a large
pool of patients which means recruiting many general
practices and a flexible approach to contacting what is
largely a young working population. We have developed
and evaluated a telephone headache classification inter-
view that can be used by a non-headache specialist to
classify chronic headache disorders. We have provided
essential evidence in support of a newly modified
headache-specific measure, for application alongside
established headache-specific and generic measures in
this population. Despite our best efforts to involve lay
people with chronic headache in the delivery of the
intervention it was difficult due to their own person
health; from a pragmatic stance the intervention was
feasible when delivered by two health care practitioners.
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